The Approval Process in Action
Source: The Life Sciences Report and Visual Capitalist (5/1/13)
What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.
Related Articles
Maxim Raises Target Price of Biotech Company
Source: Streetwise Reports (08/16/2017)
'Keep a Close Eye On' This Regenerative Medicine Firm
Source: Streetwise Reports (08/16/2017)
Immunotherapy Company's Q2 Revenue 'Handily Beats' H.C. Wainwright's Projection
Source: Streetwise Reports (08/16/2017)
Cell Therapy for Melanoma Impresses in
Phase 2
Source: Streetwise Reports (08/09/2017)
Over-the-Counter Treatments for Joint Pain and Women's Health Propel Company into New Markets
Source: Streetwise Reports (08/09/2017)
Company Developing Cannabinoid-Based Drug Therapy for Concussions Completes Reverse Takeover
Source: Streetwise Reports (08/07/2017)
This Just Changed Everything: Green Profits Are Being Unleashed
Source: Kenneth Ameduri for Streetwise Reports (08/03/2017)
Loan Provides Driver for Growth for Medical Device Firm
Source: Streetwise Reports (08/02/2017)
Canadian Medical Cannabis Provider Expanding into US Market Through RTO
Source: Streetwise Reports (07/25/2017)
Progress in Pain Control and Liver Disease Programs Spurs Rise in Company's Rating
Source: Streetwise Reports (07/19/2017)
